美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR KBW Capital Markets ETF

159.32

-3.2751-2.01%

盤後：159.320.00000.00%19:30 EDT

成交量：66.91萬

成交額：1.07億

市值：4.46億

市盈率：15.04

高：160.56

開：160.56

低：158.90

收：162.60

52周最高：173.07

52周最低：132.31

股本：280.00萬

流通股本：280.00萬

量比：49.42

換手率：23.90%

股息：2.68

股息率：1.68%

每股收益(TTM):10.59

每股收益(LYR):3.09

淨資產收益率：1.92%

總資產收益率：1.11%

市淨率：1.06

市盈率(LYR):51.53

資料載入中...

總覽公司新聞資訊公告

證監會同意優邦科技創業板IPO註冊

多家券商收緊個人程序化交易接入

多家券商收緊個人程序化交易接入

天健新材終止北交所IPO

印度國家證券交易所以最高約460億美元估值啓動IPO

环球市场播报

受試者死亡風波突襲 IPO 關鍵期易慕峯生物多重風險待考

莎普愛思深陷業績困局：主業疲軟、併購踩雷，非經常性損益撐住賬面盈利

麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂

傲雷科技IPO：代持四年無合規證明，對賭隨時復活，91.93%表決權一人獨攬

爺爺的農場IPO折戟：269個SKU幾乎全部代工，27人管品控的「輕資產」豪賭營銷費用是研發的16倍

【券商聚焦】中郵證券維持毛戈平（01318）買入評級指彩妝高增驅動業績

【券商聚焦】中信建投維持紫金黃金國際（02259）買入評級指業績高增

【券商聚焦】國海證券維持心動公司（02400）買入評級指遊戲及TapTap穩健

【券商聚焦】興業證券首予劑泰科技（07666）增持評級指其AI平台能力獲驗證

手機開户選哪家券商的APP最順暢？求推薦

【券商聚焦】華興證券維持安踏體育（02020）買入評級指多品牌佈局賦予增長確定性

【券商聚焦】國泰海通維持吉利汽車（00175）增持評級指其具備全球頭部車企競爭力

【券商聚焦】國盛證券維持翰森製藥（03692）買入評級指創新管線步入兑現期

香港銀行業2030報告：建議將互聯互通框架擴展至新股通，允許內地投資者參與香港IPO

【券商聚焦】招銀國際首予瀚天天成（02726）「買入」評級指境內外雙輪驅動

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/KCE/news?page=11"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KCE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCE\",,,,,undefined,":{"symbol":"KCE","market":"US","secType":"STK","nameCN":"SPDR KBW Capital Markets ETF","latestPrice":159.32,"timestamp":1789502400000,"preClose":162.5951,"halted":0,"volume":669072,"hourTrading":{"tag":"盘后","latestPrice":159.32,"preClose":159.32,"latestTime":"19:30 EDT","volume":61,"amount":9716.24,"timestamp":1789515007126,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.020142673426198014,"floatShares":2800000,"shares":2800000,"eps":10.591066,"marketStatus":"已收盤","change":-3.2751,"latestTime":"09-15 16:00:00 EDT","open":160.56,"high":160.56,"low":158.9,"amount":106865163.37584001,"amplitude":0.010209,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":10.591066,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":162.5951,"sharesOutstanding":3250000,"nav":162.630268,"aum":455364751.02,"dividendRate":0.016816,"bidAskSpread":0.001529,"postHourTrading":{"tag":"盘后","latestPrice":159.32,"preClose":159.32,"latestTime":"19:30 EDT","volume":61,"amount":9716.24,"timestamp":1789515007126,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":49.423966,"impliedVol":0.181,"impliedVolPercentile":0.6653},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCE\",,,,,undefined,":{"symbol":"KCE","floatShares":2800000,"roa":"1.11%","roe":"1.92%","lyrEps":3.09153,"volumeRatio":49.423966,"shares":2800000,"dividePrice":2.679135,"high":160.56,"amplitude":0.010209,"preClose":162.5951,"low":158.9,"week52Low":132.305,"pbRate":"1.06","psRate":"44.07","week52High":173.07,"institutionHeld":16.2854,"latestPrice":159.32,"eps":10.591066,"divideRate":0.016816,"volume":669072,"delay":0,"ttmEps":10.591066,"open":160.56,"prevYearClose":149.9292,"prevWeekClose":163.28,"prevMonthClose":171.03,"prevQuarterClose":147.2354,"fiveDayClose":168.3,"twentyDayClose":166.57,"sixtyDayClose":154.8674},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KCE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"KCE","amount":0.697053,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"KCE","amount":0.717599,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"KCE","amount":0.726809,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"KCE","amount":0.537674,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"KCE","amount":0.59588,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KCE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.227106,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.286677,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.327788,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.241445,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.260841,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KCE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KCE\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666540602","title":"證監會同意優邦科技創業板IPO註冊","url":"https://stock-news.laohu8.com/highlight/detail?id=2666540602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666540602?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:05","pubTimestamp":1789117547,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4127","FRHC","IPOS","REDS","KCE","CNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666542079","title":"多家券商收緊個人程序化交易接入","url":"https://stock-news.laohu8.com/highlight/detail?id=2666542079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666542079?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 16:29","pubTimestamp":1789115387,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547423","title":"多家券商收緊個人程序化交易接入","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547423","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666547423?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 16:29","pubTimestamp":1789115383,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666542675","title":"天健新材終止北交所IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666542675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666542675?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 16:08","pubTimestamp":1789114111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCE","FRHC","BK4127","REDS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666542662","title":"印度國家證券交易所以最高約460億美元估值啓動IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666542662","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666542662?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 16:07","pubTimestamp":1789114020,"startTime":"0","endTime":"0","summary":"印度国家证券交易所将首次公开募股价格区间确定为每股1700至1785卢比，按上限计算，发行规模约2256亿卢比，折合约23.6亿美元，对应公司估值约4.42万亿卢比、约合460亿美元。发行规模较原方案缩减约15%根据招股文件，NSE此次计划出售最多1.264亿股，每股面值1卢比。印度证券交易委员会于2026年1月出具无异议文件，并在NSE重新提交招股书后，于9月4日给出最终审核意见。NSE是印度交易规模最大的证券交易所。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-11/doc-inirmvzx5416359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4582","REDS","IPOS","FRHC","KCE","MNDmain","BK4127","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666254467","title":"受試者死亡風波突襲 IPO 關鍵期 易慕峯生物多重風險待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2666254467","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666254467?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:37","pubTimestamp":1789112220,"startTime":"0","endTime":"0","summary":"核心产品 IMC002 的 III 期注册临床试验发生受试者死亡事件，叠加家属对风险告知、临床处置、企业沟通的多重质疑，恰逢公司二次递交港股 IPO 申请，将这家以 CAR\u001eT 疗法为核心资产的创新药企推至聚光灯下。该起已经发生的受试者死亡事件是否属于需要强制披露的重大事件，有待监管层面进一步核实判断。临床试验安全管理、信息披露合规、投资者信心，三道考题同时摆在这家冲刺 IPO 的生物科技公司面前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5386593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FRHC","KCE","IPOS","REDS","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446065","title":"莎普愛思深陷業績困局：主業疲軟、併購踩雷，非經常性損益撐住賬面盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446065","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666446065?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:36","pubTimestamp":1789112160,"startTime":"0","endTime":"0","summary":"曾经凭借白内障滴眼液被大众熟知的莎普爱思，正持续面临经营层面的多重压力。02医疗服务并购接连失速，关联收购折戟暴露治理隐患医药制造、医疗服务是莎普爱思两大业务板块，而医疗服务板块已经连续多年成为业绩拖累项。整体来看，莎普爱思当下依靠投资收益等非经常性损益粉饰账面利润，主营业务已经陷入亏损。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5386170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603168","BK4588","CALF","XMMO","MYLD","KCE","BK0239","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","XMMO","LNGR","02041","MYLD","RSPH","MEDX","LGHT","BK1574","159883","KCE","PTH","09996","BK4585","AGNG","IEIH","BK1583","GDOC","CALF","BK4588","HART","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666723542","title":"傲雷科技IPO：代持四年無合規證明，對賭隨時復活，91.93%表決權一人獨攬","url":"https://stock-news.laohu8.com/highlight/detail?id=2666723542","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666723542?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:12","pubTimestamp":1789110720,"startTime":"0","endTime":"0","summary":"另外，范江通过直接持股及担任14个持股平台执行事务合伙人的方式，合计掌控公司91.93%的表决权，同时兼任董事长与总经理。2023年至2025年，傲雷科技累计确认股份支付费用约9214万元。2025年傲雷科技归母净利润8423.2万元，创三年新高；但同期经营活动现金流净额从2024年的1.13亿元骤降至7918.98万元，降幅达30%。关联交易方面，东莞市长源丰精密五金制品有限公司由傲雷科技员工张超逸的姐夫林根持股59%并担任总经理。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/newstock/2026-09-11/doc-inirmvzu6876737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FRHC","IPOS","BK4127","REDS","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546402","title":"爺爺的農場IPO折戟：269個SKU幾乎全部代工，27人管品控的「輕資產」豪賭 營銷費用是研發的16倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546402","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546402?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:15","pubTimestamp":1789107300,"startTime":"0","endTime":"0","summary":"隐忧一：269个SKU几乎全部代工，27人管品控的“轻资产”豪赌招股书揭开了这家公司最核心的风险敞口。截至2025年9月，爷爷的农场旗下269个SKU几乎全部依赖外部代工生产，合作的OEM制造商多达62家，其中49家位于国内。营销费用分别是研发开支的11.37倍、10.8倍和16.45倍。有业内人士指出，爷爷的农场IPO折戟，并非只是单一的上市受阻，而是整个婴童零辅食行业“重营销、轻产品”模式在资本市场与消费端同时面临新审视的缩影。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmrtw6951782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK4127","REDS","KCE","FRHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666461695","title":"【券商聚焦】中郵證券維持毛戈平（01318）買入評級 指彩妝高增驅動業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2666461695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666461695?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:14","pubTimestamp":1789107258,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中邮证券发布研报指，毛戈平 发布2026年中期业绩，上半年实现营业收入32.67亿元，同比+26.2%；归母净利润8.06亿元，同比+20.3%；经调整净利润8.15亿元，同比+21.3%；毛利率84.8%，同比+0.6pct；董事会建议派发中期股息每股人民币0.62元。收入端呈现彩妆高增驱动、线上首超线下的结构性变化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991379","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01318","161027","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546187","title":"【券商聚焦】中信建投維持紫金黃金國際（02259）買入評級 指業績高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546187","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546187?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:11","pubTimestamp":1789107084,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投发布研报指，紫金黄金国际 2026年上半年实现营业收入39.87亿美元，同比增长99.67%；归母净利润14.51亿美元，同比增长178.83%。业绩高增的核心驱动力来自黄金价格上涨及矿产金产量增加。产量方面，2026年上半年公司矿产金总产量为27.3吨，同比约增长44%。产量增长主要源于2025年新收购的加纳阿基姆金矿和哈萨克斯坦瑞果多金矿在本报告期内实现全年并表，分别贡献产量4.0吨和3.3吨；武里蒂卡、罗斯贝尔等成熟矿山亦实现稳健增产。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991423","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","02259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666152546","title":"【券商聚焦】國海證券維持心動公司（02400）買入評級 指遊戲及TapTap穩健","url":"https://stock-news.laohu8.com/highlight/detail?id=2666152546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666152546?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:03","pubTimestamp":1789106585,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国海证券发布研报指，心动公司 2026年上半年实现营业收入33.12亿元，同比增长7.5%；经调整净利润7.72亿元，同比下降3.0%。中期业绩受一次性补税扰动，公司自查评估补缴企业所得税及相关附加费，其中0.97亿元确认为2026H1所得税支出，抬升当期税负水平；同时AI相关运算成本同比大幅增加至0.71亿元。公司于2026年1月启动AI游戏创作智能体TapTap Maker邀请测试，目前已有超6000款游戏利用该智能体开发并在TapTap上发布。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991394","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02400","KCE","000750"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546150","title":"【券商聚焦】興業證券首予劑泰科技（07666）增持評級 指其AI平台能力獲驗證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546150","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546150?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:03","pubTimestamp":1789106581,"startTime":"0","endTime":"0","summary":"金吾财讯 | 兴业证券发布研报指，剂泰科技-P 2026H1实现营业收入1.54亿元，同比增长13399%，经调整净亏损为5110万元，同比减亏56.4%，经营效率显著改善。公司针对自身免疫疾病的临床前TCE管线MTS-128实现对外授权。公司与由Deerfield支持的美国生物科技公司Boulevard Bio达成MTS-128全球独家授权协议，公司将获得2000万美元首付款，并有资格获得最高达16亿美元的开发、注册及商业化里程碑付款，以及分级销售分成。该授权验证了公司将AI与蛋白药物设计深度融合的平台能力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991413","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601377","VTHR","CHAT","KCE","AGIX","ARTY","QTOC","07666","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546842","title":"手機開户選哪家券商的APP最順暢？求推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546842","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546842?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:56","pubTimestamp":1789106160,"startTime":"0","endTime":"0","summary":"开户环节：3分钟办结，不再“盲选”券商。传统开户模式是下载某家券商的APP、注册、提交资料，全程不知道自己的佣金费率是否划算。多家头部券商APP的默认佣金普遍在万2.5至万3之间，中信证券默认万3，华泰证券默认万2.854。这是新浪财经APP区别于纯券商APP的核心优势。对于大多数普通投资者而言，这可能是2026年手机开户最“顺畅”的一条路径。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmrtz5412958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666463765","title":"【券商聚焦】華興證券維持安踏體育（02020）買入評級 指多品牌佈局賦予增長確定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2666463765","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666463765?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:52","pubTimestamp":1789105955,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华兴证券发布研报指，安踏体育 短期运营仍存波动，但多品牌、多品类、多渠道布局赋予增长确定性，维持“买入”评级，目标价109.00港元，对应16倍2027年P/E，较当前股价73.50港元仍有48%上行空间。在中秋错期带来部分消费前置的预期下，该机构预计9月流水有望持续改善，三季度安踏品牌流水增速介于±2%区间，FILA品牌流水同比增长3%-5%，其他品牌流水增长约20%。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991384","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02020","161027","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371546","title":"【券商聚焦】國泰海通維持吉利汽車（00175）增持評級 指其具備全球頭部車企競爭力","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371546?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:52","pubTimestamp":1789105945,"startTime":"0","endTime":"0","summary":"吉利汽车通过整合极氪和领克，发挥业务协同和规模效应，提升核心竞争力；同时对管理层任命进行调整，完善职业经理人授权经营机制，以现代企业治理体系做强“一个吉利”。风险提示包括新车销量风险、关税风险及原材料涨价风险。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991391","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","02611","00175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546373","title":"【券商聚焦】國盛證券維持翰森製藥（03692）買入評級 指創新管線步入兑現期","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546373","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:52","pubTimestamp":1789105941,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国盛证券发布研报指，翰森制药 2026年上半年实现营业收入83.04亿元，同比增长11.7%；归母净利润42.58亿元，同比增长35.8%；扣非归母净利润41.16亿元，同比增长32.0%。B7-H3ADC国内上市申请获受理，GSK启动其第二项全球III期研究。9月3日，GSK注册了HS-20093治疗转移性去势抵抗性前列腺癌的第二项全球III期临床，计划入组684例患者。创新管线步入成果兑现期。通过可比公司估值法，给予公司2026年37倍PE，对应目标价40.89港元，维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","03692","002670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666954579","title":"香港銀行業2030報告：建議將互聯互通框架擴展至新股通，允許內地投資者參與香港IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666954579","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666954579?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:46","pubTimestamp":1789105613,"startTime":"0","endTime":"0","summary":"报告显示，99%的受访银行对香港银行业的未来发展前景持正面态度。在互联互通方面，为进一步深化与内地的金融联通，报告建议将互联互通框架扩展至新股通，允许内地投资者参与香港IPO，同时加快将人民币计价交易柜台纳入互联互通，允许内地投资者以人民币买卖香港上市股份；厘清跨境理财通下的销售及推广活动范围，并协调记账中心之间的客户覆盖及统一投资组合可视性。报告亦建议促进大湾区专业资格互认。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4127","FRHC","KCE","IPOS","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666644545","title":"【券商聚焦】招銀國際首予瀚天天成（02726）「買入」評級 指境內外雙輪驅動","url":"https://stock-news.laohu8.com/highlight/detail?id=2666644545","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666644545?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:18","pubTimestamp":1789103895,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，瀚天天成 1H26 收入同比增长 92.0%至人民币 5.78 亿元，毛利率升至 27.8%，归母净利润 0.49 亿元。该机构预计公司 2026-2028 年收入分别达到人民币 13.1 亿元、29.5 亿元和53.2 亿元，归母净利润分别为 1.3 亿元、5.0 亿元和 9.5 亿元，经调整净利润分别为 3.1 亿元、6.6 亿元和 11.1 亿元。未来股价的核心驱动力在于 8 英寸放量、下游应用多元化与高压化带来的量价齐升及毛利率修复的兑现节奏。首次覆盖瀚天天成，给予“买入”评级，目标价 161.18 港元。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991410","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","02726"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":37,"pageCount":11,"totalSize":724,"code":"91000000","status":"200"}]}}